missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. PTOV1 Antibody - Azide and BSA Free, Novus Biologicals™
  7. 18686921

PTOV1 Antibody - Azide and BSA Free, Novus Biologicals™

Rabbit Polyclonal Antibody

Brand:  Novus Biologicals NBP2-93875-0.02ml

 View more versions of this product

Product Code. 18686921

This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
 View alternative products »

This item is not returnable. View return policy

Description

Description

PTOV1 Polyclonal antibody specifically detects PTOV1 in Human samples. It is validated for Western Blot
TRUSTED_SUSTAINABILITY
Specifications

Specifications

PTOV1
Polyclonal
Western Blot 1:500-1:2000
ACID2, Activator interaction domain-containing protein 2, DKFZp586I111, MGC71475, prostate tumor overexpressed 1, prostate tumor overexpressed gene 1, PTOV-1
A synthetic peptide corresponding to a sequence within amino acids 1-100 of human PTOV1 (NP_001292037.1). MRSPAVPTPARGQLGVAFVLLPPHSEGARVFGALGPIGPSSPGLTLGGLAVSEHRLSNKLLAWSGVLEWQEKRRPYSDSTAKLKRTLPCQAYVNQGENLE
0.02 mL
Cancer, Cell Biology, Cell Cycle and Replication
53635
Store at -20°C. Avoid freeze-thaw cycles.
IgG
Western Blot
Unconjugated
PBS (pH 7.3), 50% glycerol
Rabbit
Affinity purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.